Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Genta to request review of Genasense's non-approvable status

June 20, 2007

NOV-002 slows disease progression in platinum-resistant ovarian cancer

June 20, 2007

Recent clinical data on nilotinib in leukemia presented

June 20, 2007

NicOx takes precautionary measures on NCX-4016 program

June 19, 2007

Apo2L/TRAIL in patients with advanced tumors

June 19, 2007

Novel anticancer agents disclosed in recent patents

June 19, 2007

Encouraging results with targeted radiotherapy in advanced lung cancer patients

June 18, 2007

A phase I study of SSR-244738 in patients with refractory solid tumors

June 18, 2007

Biovitrum's novel tyrosine kinase inhibitor shows preclinical activity against AML

June 18, 2007

Phase II study shows tipifarnib is active in relapsed/refractory acute myeloid leukemia

June 18, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...